Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.
about
Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone MetastasesDissecting Tumor-Stromal Interactions in Breast Cancer Bone MetastasisHealth state utilities associated with adult attention-deficit/hyperactivity disorder.An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study.The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases.The role of the bone microenvironment in skeletal metastasis.Cancer to bone: a fatal attraction.Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report.Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastasesExpression of PGK1 by prostate cancer cells induces bone formation.Recent advances in cancer pain management.Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.Emerging therapeutic targets in breast cancer bone metastasis.Denosumab: in the prevention of skeletal-related events in patients with bone metastases from solid tumours.Implication of platelet-derived growth factor receptor alpha in prostate cancer skeletal metastasisDenosumab in the prevention of skeletal-related events in patients with bone metastases from solid tumors: profile report.Mesenchymal stem cells in tumor development: emerging roles and concepts.Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases.Platelets govern pre-metastatic tumor communication to bone.Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data.Osteotropic Cancers: From Primary Tumor to Bone
P2860
Q26738400-43E0E966-8713-4DD9-87B4-2AEA8A5CA85BQ26749368-E4109AAD-81DB-4739-8213-AA82F6B40CA2Q33944593-A5A7D141-C775-42F5-8EC2-92CC51C4C4FBQ34125314-4C2C397F-2766-41DB-A73B-A0D9439C63B9Q34441622-3D39E072-BA95-4E3B-9D82-6D4B8CF909B5Q35079440-83C838A5-06BD-4692-B284-4F8B7AC352E2Q35263110-FB025E29-4209-401B-B27A-7B3A3827C9E7Q35792851-5C23C00D-F012-44C8-8E6D-EBCCAEEC1CA2Q36491430-9628F81B-48E7-439C-AC29-0F0C54490EE8Q36884628-141E1897-00CE-4C59-A4B2-549C18FB6A2BQ36959955-248F6A0C-5AF2-4210-B8B1-E53AC0E0FC53Q37163756-B9C4945F-B854-4780-BB68-BFC9045E8496Q37408823-9D5EFF9A-D3D8-4C00-998C-EDEFA00763E9Q37552355-2EC92EA0-1F7F-4009-9DEB-41AFEAAE1FC1Q37577926-EF3707D4-31F6-40F4-A141-3C6DB0C3FC30Q37658767-E4A16A04-44A2-4E12-8608-2FE727864CFAQ37888670-19A26FCA-A662-495E-9B61-4E34CE076072Q37924342-0784597C-A692-4B30-9222-1AD46C88E73EQ37952289-84F45D09-5380-44AC-9DA1-41BA13DD6C04Q38032086-649DEA97-670C-4472-9605-5444B6BFFE81Q38091994-9BF7D669-D43E-42EF-940E-250C8DD0686CQ39258789-F4DFB032-C731-41C2-974E-2F49E7B7243EQ52670810-1C652C7C-1DA8-49C6-A9EB-EF820F51E426Q58327148-FC7A9024-3ABF-46D9-BB92-4E6A3DD8069D
P2860
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Advancing treatment for metast ...... e Second Cambridge Conference.
@ast
Advancing treatment for metast ...... e Second Cambridge Conference.
@en
type
label
Advancing treatment for metast ...... e Second Cambridge Conference.
@ast
Advancing treatment for metast ...... e Second Cambridge Conference.
@en
prefLabel
Advancing treatment for metast ...... e Second Cambridge Conference.
@ast
Advancing treatment for metast ...... e Second Cambridge Conference.
@en
P2093
P2860
P50
P1476
Advancing treatment for metast ...... e Second Cambridge Conference.
@en
P2093
Allan Lipton
Brendan F Boyce
Eugene V McCloskey
G David Roodman
James R Berenson
Jean-Jacques Body
Katherine N Weilbaecher
Matthew R Smith
Peyman Hadji
P2860
P304
P356
10.1158/1078-0432.CCR-08-1572
P407
P577
2008-10-01T00:00:00Z